Clinical Studies Investigating the Use of Leuprorelin in Breast Cancer Patients from Asia

Leuprorelin is a synthetic analogue of naturally occurring gonadotropin-releasing hormone. It is currently approved in the United States, Europe and Asia and has indications in advanced prostate cancer, endometriosis, breast cancer and precocious puberty. This review examined clinical trials of leup...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Wonshik, Youn, Hyun Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857887/
https://www.ncbi.nlm.nih.gov/pubmed/31127911
http://dx.doi.org/10.31557/APJCP.2019.20.5.1475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857887/
https://www.ncbi.nlm.nih.gov/pubmed/31127911
http://dx.doi.org/10.31557/APJCP.2019.20.5.1475

Ejemplares similares